Gene-environment interaction in chronic disease: A European Science Foundation Forward Look - 25/11/11
![](/templates/common/images/mail.png)
![](/templates/common/images/entites/lowast.gif)
![](/templates/common/images/entites/lowast.gif)
Abstract |
Over the last half century, a dramatic increase in the incidence of chronic inflammatory diseases, such as asthma, allergy, and irritable bowel syndrome, has rightfully led to concern about how the modern lifestyle might inappropriately trigger innate physiologic defense mechanisms. Health care research in the Western world is faced with a significant challenge if it is to meet the needs of its populations in the decades ahead. The tools with which we hope to advance our understanding of the intrinsic and extrinsic mechanisms of chronic inflammatory diseases must therefore be adequately exploited and further developed to identify treatment and prevention strategies. There is an urgent need to prioritize resources and identify the most efficient scientific and societal initiatives to be adopted within this area. In this context national collaboration within Europe and beyond to establish state-of-the-art practices with an interdisciplinary perspective and promote an efficient exchange of best practices is essential. Such an approach likely represents the most efficient manner in which strategies for amelioration of the increase of chronic inflammatory diseases in the Western world can be achieved. The present report is based on a Forward Look initiative conducted by the European Medical Research Councils under the European Science Foundation. Experts from industry and academia, as well as relevant interest organizations, have been consulted in the process of conducting this initiative and have, based on this work, developed a set of final recommendations that target academic research, science funders, and policy makers.
Le texte complet de cet article est disponible en PDF.Key words : Gene-environment, inflammation, immunology, chronic disease, Europe, lifestyle, genetic factors, interdisciplinary, policy, foresight
Abbreviations used : EMRC, ER, ESF, GWAS, IBD, MLN, NF-κB, NOD, SNP, SPF, T1D, T2D, TLR, Treg
Plan
This Forward Look was financed by the European Science Foundation. |
|
Publication of this article was supported by the European Science Foundation. |
|
Disclosure of potential conflict of interest: E. von Mutius is a consultant for Novartis, GlaxoSmithKline, ALK-Abelló, and Protectimmun; has received speaker’s fees from InfectoPharm; has received research support from Airsonnett AB; is a member of the Expert Panel for the UK Research Excellence Framework; and is Associate Editor of the Journal of Allergy and Clinical Immunology. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 128 - N° 6S
P. S27-S49 - décembre 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?